UnitedHealthcare’s Proposed 2026 RPM Coverage Cuts: What It Means for Your Practice and Why Medicare Fee-for-Service Still Has You Covered

Medical practice administrator reviewing a UHC policy warning document alongside an RPM health dashboard showing positive patient outcomes, illustrating the contrast between UHC's 2026 RPM coverage cuts and Medicare fee-for-service expansion
Table of Contents
    Add a header to begin generating the table of contents

    Key Takeaways

    •

    UnitedHealthcare (UHC) announced plans to restrict RPM coverage to only two conditions: heart failure and hypertensive disorders of pregnancy, across its Medicare Advantage, commercial, and Medicaid plans.

    •

    The policy has been delayed from its original January 1, 2026, effective date. UHC has confirmed it still intends to implement the restriction at a later date in 2026, with advance notice to providers.

    •

    UHC is the outlier. Traditional Medicare fee-for-service is moving in the exact opposite direction by expanding RPM access, increasing reimbursement rates, and introducing new CPT codes in 2026.

    •

    Practices should act now. Audit your UHC RPM panel, identify at-risk patients, and evaluate program alternatives before the new effective date is announced.

    •

    RPM Logix helps practices build diversified, Medicare-anchored remote care programs that are protected from commercial payer volatility.
    If you serve UnitedHealthcare patients and run a Remote Patient Monitoring (RPM) program, this is the update you need to read carefully and act on.
    In late 2025, UnitedHealthcare announced sweeping plans to restrict RPM coverage across its Medicare Advantage, commercial, and Medicaid plans. The proposed change, which would limit reimbursement to just two qualifying conditions, sent shockwaves through the provider community and sparked intense industry pushback. UHC delayed implementation from January 1, 2026, but it has been clear: the policy is coming. The revised timeline just hasn’t been announced yet.
    For practices that have built RPM into their chronic care workflows, this creates an urgent planning problem. The good news is that traditional Medicare fee-for-service, the foundation of RPM reimbursement for most practices, is doing the opposite. CMS expanded RPM access, increased reimbursement rates, and added new CPT codes in its 2026 Physician Fee Schedule Final Rule.
    Here is what every practice needs to know right now ↓

    Where Things Stand Right Now

    On December 17, 2025, UHC notified providers via email that it was postponing the policy’s January 1 effective date. The delay came after fierce pushback from provider groups, medical societies, advocacy organizations, and legal experts who argued the policy contradicted CMS guidance and ignored a substantial body of clinical evidence.
    A UHC spokesperson confirmed: the policy is delayed, not cancelled. UHC has stated it still intends to implement the restriction in 2026 and will provide advance notice with a new effective date once finalized.
    As of the date of this article, no new implementation date has been announced. Practices can continue billing UHC for RPM across all current eligible conditions until that date is communicated.
    The bottom line for your practice: this is a window, not a resolution. Use the time left wisely.

    What UnitedHealthcare Actually Announced

    UHC’s proposed RPM policy, originally scheduled to take effect January 1, 2026, would classify RPM as “proven and medically necessary” for only two conditions:
    • 1.

      Chronic heart failure

    • 2.

      Hypertensive disorders of pregnancy

    For every other condition, including Type 2 diabetes, general hypertension, COPD, and obesity, UHC would classify RPM as “unproven and not medically necessary.” That language matters. It means claims for those conditions would be denied outright, not just subject to prior authorization.
    The policy applies across all UHC plan types:
    • UnitedHealthcare Medicare Advantage
    • UnitedHealthcare Commercial and Individual Exchange plans
    • UnitedHealthcare Community Plan (Medicaid)
    This is not a minor coverage adjustment. For practices with a significant UHC patient population enrolled in RPM for diabetes, hypertension, or COPD, the revenue impact could be substantial.
    CONDITION UHC STATUS MEDICARE FEE-FOR-SERVICE
    Chronic Heart Failure Covered Covered
    Hypertensive Disorders of Pregnancy Covered Covered
    Type 2 Diabetes AT RISK Covered
    General Hypertension AT RISK Covered
    COPD AT RISK Covered
    Obesity AT RISK Covered
    Obstructive Sleep Apnea (OSA) AT RISK Covered
    *UHC policy status reflects the delayed policy intent, not current enforcement. All conditions remain billable under UHC until the new effective date is announced.

    What This Means for Your RPM Panel: A 4-Step Action Plan

    If UHC is a significant payer for your practice, here are smart, actionable steps you can take to manage your RPM program amid this uncertainty.
    🔍 Step 1: Audit Your UHC RPM Population
    ✅ ▼
    ✔️ Pull a list of all patients currently enrolled in your RPM program who have UHC coverage, including Medicare Advantage, Commercial, or Medicaid. ✔️ For each patient, identify their primary diagnosis driving RPM enrollment. ✅ Patients enrolled for heart failure or hypertensive disorders of pregnancy will likely be unaffected when the policy takes effect. ❌ Patients enrolled for Type 2 diabetes, general hypertension, COPD, or other conditions are at risk of losing UHC reimbursement for RPM.
    🔄 Step 2: Evaluate Program Alternatives for At-Risk Patients
    ✅ ▼
    Losing RPM reimbursement for a UHC patient does not mean the patient can no longer receive care management services; available alternatives depend significantly on which UHC plan type covers that patient. For UHC Medicare Advantage Patients: Medicare Advantage plans are required to cover all services covered by traditional Medicare fee-for-service. That means CCM, PCM, and APCM, all Medicare programs, remain available as structured alternatives for your UHC Medicare Advantage patients who lose RPM reimbursement under the new policy. For UHC Commercial and Medicaid Patients: CCM, PCM, and APCM are Medicare programs and are not available as alternatives for patients covered under UHC commercial or Medicaid plans. For those patients, the honest reality is that UHC’s policy change may leave no reimbursable RPM or care management substitute under those specific plans. This is precisely why building your remote care program on a Medicare fee-for-service foundation, rather than on commercial payer coverage, is the most defensible long-term strategy. For your Medicare and Medicare Advantage patients, the following programs are available as alternatives: Chronic Care Management (CCM): For patients with two or more chronic conditions, CCM provides monthly care coordination, care plan management, and care team touchpoints, all of which are reimbursed under Medicare and most commercial plans. Principal Care Management (PCM): For patients with a single high-complexity chronic condition, PCM offers a similar framework focused on that specific condition. Advanced Primary Care Management (APCM): For practices already delivering comprehensive primary care, APCM provides a longitudinal care management framework that integrates well across complex patient populations. None of these programs replaces RPM’s device-based monitoring capabilities, but for your UHC Medicare patients specifically, they do ensure those patients remain in a reimbursable, structured care program. Need help managing your at-risk patients? RPM Logix can help you find the right program before the policy takes effect. Schedule a Strategy Call →
    📋 Step 3: Document Clinical Outcomes for Your RPM Population
    ✅ ▼
    If UHC implements the policy and your practice continues to believe RPM is medically necessary for a specific patient, documentation of clinical outcomes becomes your most important tool. Real-world data showing improved blood pressure control, reduced ER visits, or better HbA1c levels for patients in your RPM program strengthens both individual appeal cases and broader advocacy efforts.
    📅 Step 4: Monitor for the New Effective Date
    ✅ ▼
    UHC has committed to providing advance notice before the policy takes effect. Watch your UHC provider communications closely. When the new date is announced, you will want your panel audit and transition plan already in place, not started from scratch.

    What Traditional Medicare Is Doing Instead

    While UHC moves to restrict, CMS and traditional Medicare fee-for-service are doing the opposite. This is the context that every practice needs to keep front of mind.

    The 2026 Medicare Physician Fee Schedule Final Rule expanded RPM in three meaningful ways:

    ❗️

    New CPT code 99445 created a reimbursable billing tier for patients who transmit device data for just 2 to 15 days in a 30-day period, eliminating the all-or-nothing gap that previously left shorter monitoring windows uncompensated.

    ❗️

    New CPT code 99470 created a 10 to 19-minute Care Team time tier, allowing practices to bill for shorter, high-value clinical touchpoints that previously fell below the 20-minute threshold for CPT 99457.

    ❗️

    Reimbursement rates for RPM increased 7 to 21% across the existing CPT code set, reflecting CMS’s continued investment in remote care as a core component of value-based chronic disease management.

    Traditional Medicare covers RPM for any patient with an acute or chronic condition where the treating provider documents medical necessity. There is no condition-specific restriction. Diabetes, hypertension, COPD, obesity, and obstructive sleep apnea ALL qualify. And for OSA patients specifically, RPM Logix’s Sleep Buddy program provides a fully managed RPM and CCM solution built around PAP therapy adherence monitoring.

    Beyond Medicare, the broader payer landscape is also expanding RPM coverage. As of 2026, 42 state Medicaid programs cover RPM, and commercial payer coverage continues to grow.

    Why Providers and Medical Societies Pushed Back

    The clinical and legal objections raised against UHC’s policy were significant and well-documented.

    🔬 On the Clinical Side

    The evidence base for RPM in conditions like hypertension and diabetes is substantial. Studies have consistently shown that remote blood pressure monitoring improves control rates, that glucose monitoring for diabetes reduces hospitalizations, and that ongoing remote monitoring for COPD reduces exacerbations and emergency visits. The claim that RPM for these conditions is “unproven” contradicts a decade of peer-reviewed research and real-world program data.

    ⚖️ On the Legal Side

    Experts pointed to a 2024 CMS rule requiring Medicare Advantage plans to provide at least the same level of coverage as traditional Medicare fee-for-service. Since traditional Medicare covers RPM for any acute or chronic condition with documented medical necessity, UHC’s blanket exclusion of entire diagnosis categories, without any individualized patient analysis, raised serious compliance concerns. Legal experts described it as an aggressive and questionable use of plan-defined coverage authority.

    That combination of clinical and legal pressure, amplified by providers and industry advocates, is what pushed UHC to delay. Whether it will be enough to change the policy permanently remains to be seen.

    The Bigger Picture: Why Medicare Fee-for-Service Is Your RPM Anchor

    The UHC situation illustrates a broader principle that every practice managing a remote care program should internalize: commercial payer RPM coverage is variable and subject to change. Medicare fee-for-service is not.

    CMS has invested years of policy development, code creation, and reimbursement increases into building RPM as a sustainable, scalable care management model. The 2026 fee schedule updates reinforce that commitment. Medicare Advantage plans are required to provide at least equivalent coverage to traditional Medicare, and UHC’s attempt to carve out RPM coverage is facing both legal scrutiny and regulatory pressure as a result.

    For practices that have relied heavily on commercial or Medicare Advantage payers for RPM reimbursement, the UHC situation is a signal to re-evaluate your RPM panel’s payer mix and ensure your program is built on a Medicare fee-for-service foundation.

    It is also a reminder that the highest-value RPM strategy is not just about enrollment numbers. It is about matching each patient to the right program:

    📱 RPM

    Where device-based monitoring drives clinical decisions.

    🤝 CCM

    Where care coordination and monthly touchpoints are the primary need.

    🧠 BHI / APCM

    Where those programs are clinically appropriate and independently documented.

    When your program is built that way, no single payer policy change can destabilize it.

    How RPM Logix Helps Practices Navigate Payer Uncertainty

    At RPM Logix, we have built our programs around Medicare fee-for-service reimbursement from the ground up because it is the most stable, well-defined, and consistently expanding reimbursement pathway available for remote care management.

    Our care team, consisting of care managers (nurses), registered dietitians, and diabetes educators, handles the monthly clinical touchpoints, documentation, EHR integration, device monitoring, and care coordination that make RPM and CCM programs both compliant and reimbursable.

    When payer policies shift, our team helps your practice identify the right program path for every patient, whether that means continuing RPM under Medicare, transitioning a UHC patient to CCM, or layering BHI alongside an existing care management program.

    If you have UHC patients currently enrolled in RPM for conditions outside of heart failure or hypertensive disorders of pregnancy, now is the time to have that conversation before UHC announces its new effective date.

    Schedule a Strategy Call with RPM Logix →

    Frequently Asked Questions

    Q: Is UHC’s RPM restriction in effect right now?

    No. As of the date of this article, UHC has postponed the policy, and no new effective date has been announced. Practices can continue billing UHC for RPM across all current eligible conditions. UHC has confirmed it still intends to implement the restriction in 2026.

    Q: Does the UHC policy affect traditional Medicare RPM?

    No. The UHC policy applies to UnitedHealthcare Medicare Advantage, commercial, and Medicaid plans only. Traditional Medicare fee-for-service RPM coverage and reimbursement are unchanged and were expanded in the 2026 Physician Fee Schedule Final Rule.

    Q: Will other commercial payers follow UHC’s lead?

    Based on current information, UHC is the outlier. Most commercial payers and non-UHC Medicare Advantage plans are maintaining or expanding RPM coverage. Experts note that UHC’s policy faces significant legal scrutiny given CMS requirements for Medicare Advantage plans to match traditional Medicare coverage.

    Q: What happens to my UHC patients if the policy takes effect?

    UHC patients enrolled in RPM for conditions outside of heart failure or hypertensive disorders of pregnancy would lose RPM reimbursement under that plan. Those patients may still qualify for CCM, PCM, or APCM depending on their diagnosis profile, which can provide structured monthly care management without device-based monitoring reimbursement.

    For UHC Medicare Advantage patients, CCM, PCM, or APCM may be available alternatives depending on their diagnosis profile, as Medicare Advantage plans are required to cover these Medicare programs.

    For UHC commercial and Medicaid patients, CCM, PCM, and APCM are not available; those are Medicare programs, and there may be no reimbursable substitute for RPM under those specific plans.

    Q: Can I appeal a denied RPM claim under the new UHC policy?

    Yes. Providers can submit appeals with clinical documentation supporting medical necessity for individual patients. Strong outcome documentation, showing measurable clinical improvement attributable to RPM, gives appeals the best chance of success.

    Q: How does this affect RPM for diabetes patients specifically?

    Under UHC’s proposed policy, RPM for Type 2 diabetes would be classified as “not medically necessary.“ Those patients enrolled in RPM for glucose monitoring under a UHC plan would no longer generate RPM reimbursement. CCM is typically the most appropriate alternative for diabetes patients with two or more chronic conditions.

    For UHC Medicare Advantage patients, CCM is typically the most appropriate alternative for diabetes patients with two or more chronic conditions.

    For UHC commercial and Medicaid patients, CCM is a Medicare program and is not available as a substitute under those plan types.

    For more on building a payer-resilient remote care program, explore our guides on 2026 RPM & CCM Reimbursement Increases, How APCM and CCM Work Together, RTM vs. RPM: 2026 CPT Code Changes, and the 2026 CMS Final Rule Explained.

    Note: This article reflects publicly available information as of May 4, 2026. UHC’s RPM policy remains subject to change. RPM Logix recommends monitoring UHC provider communications directly for updates on the new implementation date.

    Would you like a demo?

    This field is for validation purposes and should be left unchanged.
    Name(Required)
    This field is hidden when viewing the form

    Disclaimer

    • The information provided by RPM Logix is intended for educational purposes only and should not be construed as legal or medical billing advice. While every effort is made to ensure the accuracy and timeliness of the content, RPM Logix makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information provided. The coding and billing guidelines, including but not limited to CPT, HCPCS, and ICD codes, are subject to updates and changes by regulatory authorities such as CMS (Centers for Medicare & Medicaid Services) and the AMA (American Medical Association).
    • RPM Logix is not responsible for any errors, omissions, or outcomes resulting from the use of this information. It is the responsibility of the healthcare provider to verify the accuracy of coding and billing information, to remain informed about updates, and to comply with all relevant payer guidelines and regulations. RPM Logix strongly recommends consulting legal counsel, reimbursement specialists, or the appropriate authoritative resources before submitting any claims.
    • By using the information provided by RPM Logix, you acknowledge and agree that RPM Logix shall not be held liable for any claims, damages, or other liabilities arising from your use of the information, including but not limited to any billing, coding, or reimbursement issues that may result from reliance on the material presented.